Clinical Trial Update: Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in Spain

View source ↗

Summary

This completed clinical trial sponsored by Novartis analyzes therapeutic management and the use of resources and costs associated with spinal muscular atrophy i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Snippet

Sponsor: Novartis | Conditions: Spinal Muscular Atrophy Type I, Spinal Muscular Atrophy Type II | Status: COMPLETED